MicroRNA-141-3p Negatively Modulates SDF-1 Expression in Age-Dependent Pathophysiology of Human and Murine Bone Marrow Stromal Cells

Overview

Journal J Gerontol A Biol Sci Med Sci

Specialty Geriatrics

Date 2019 Sep 11

PMID 31505568

Citations 25

Authors

Sudharsan Periyasamy-Thandavan

John Burke

Bharati Mendhe

Galina Kondrikova

Ravindra Kolhe

Monte Hunter

Carlos M Isales

Mark W Hamrick

William D Hill

Sadanand Fulzele

Affiliations

Soon will be listed here.

Abstract

Stromal cell-derived factor-1 (SDF-1 or CXCL12) is a cytokine secreted by cells including bone marrow stromal cells (BMSCs). SDF-1 plays a vital role in BMSC migration, survival, and differentiation. Our group previously reported the role of SDF-1 in osteogenic differentiation in vitro and bone formation in vivo; however, our understanding of the post-transcriptional regulatory mechanism of SDF-1 remains poor. MicroRNAs are small noncoding RNAs that post-transcriptionally regulate the messenger RNAs (mRNAs) of protein-coding genes. In this study, we aimed to investigate the impact of miR-141-3p on SDF-1 expression in BMSCs and its importance in the aging bone marrow (BM) microenvironment. Our data demonstrated that murine and human BMSCs expressed miR-141-3p that repressed SDF-1 gene expression at the functional level (luciferase reporter assay) by targeting the 3'-untranslated region of mRNA. We also found that transfection of miR-141-3p decreased osteogenic markers in human BMSCs. Our results demonstrate that miR-141-3p expression increases with age, while SDF-1 decreases in both the human and mouse BM niche. Taken together, these results support that miR-141-3p is a novel regulator of SDF-1 in bone cells and plays an important role in the age-dependent pathophysiology of murine and human BM niche.

Citing Articles

SCD2 Regulation Targeted by miR-200c-3p on Lipogenesis Alleviates Mesenchymal Stromal Cell Senescence.

Yu X, Zhang C, Ma Q, Gao X, Sun H, Sun Y Int J Mol Sci. 2024; 25(15).

PMID: 39126105 PMC: 11313047. DOI: 10.3390/ijms25158538.

Variation in mesenchymal KITL/SCF and IGF1 expression in middle age underlies steady-state hematopoietic stem cell aging.

Young K, Telpoukhovskaia M, Hofmann J, Mistry J, Kokkaliaris K, Trowbridge J Blood. 2024; 144(4):378-391.

PMID: 38598841 PMC: 11302459. DOI: 10.1182/blood.2024024275.

How mesenchymal stem cells transform into adipocytes: Overview of the current understanding of adipogenic differentiation.

Liu S, Fang X, Wen X, Liu J, Alip M, Sun T World J Stem Cells. 2024; 16(3):245-256.

PMID: 38577237 PMC: 10989283. DOI: 10.4252/wjsc.v16.i3.245.

Mesenchymal stem cells and dental implant osseointegration during aging: from mechanisms to therapy.

Ma Y, Wang S, Wang H, Chen X, Shuai Y, Wang H Stem Cell Res Ther. 2023; 14(1):382.

PMID: 38124153 PMC: 10734190. DOI: 10.1186/s13287-023-03611-1.

Novel Function of Nogo-A as Negative Regulator of Endothelial Progenitor Cell Angiogenic Activity: Impact in Oxygen-Induced Retinopathy.

Ruknudin P, Nazari A, Wirth M, Lahaie I, Bajon E, Rivard A Int J Mol Sci. 2023; 24(17).

PMID: 37685993 PMC: 10488245. DOI: 10.3390/ijms241713185.

References

Jiang Y, Jahagirdar B, Reinhardt R, Schwartz R, Keene C, Ortiz-Gonzalez X . Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418(6893):41-9. DOI: 10.1038/nature00870. View

Zeng Y, Yi R, Cullen B . MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A. 2003; 100(17):9779-84. PMC: 187842. DOI: 10.1073/pnas.1630797100. View

Kim D, Yoo K, Choi K, Choi J, Choi S, Yang S . Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell. Cytokine. 2005; 31(2):119-26. DOI: 10.1016/j.cyto.2005.04.004. View

Dimitriou R, Tsiridis E, Giannoudis P . Current concepts of molecular aspects of bone healing. Injury. 2005; 36(12):1392-404. DOI: 10.1016/j.injury.2005.07.019. View

Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N . Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol. 2005; 6(10):1038-46. DOI: 10.1038/ni1251. View

Yu L, Cecil J, Peng S, Schrementi J, Kovacevic S, Paul D . Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene. 2006; 374:174-9. DOI: 10.1016/j.gene.2006.02.001. View

Kim K, Kim H, Kim J, Choi Y, Kim Y, Cheong J . Chemokine stromal cell-derived factor-1 induction by C/EBPbeta activation is associated with all-trans-retinoic acid-induced leukemic cell differentiation. J Leukoc Biol. 2007; 82(5):1332-9. DOI: 10.1189/jlb.1106697. View

Wagner W, Ho A . Mesenchymal stem cell preparations--comparing apples and oranges. Stem Cell Rev. 2007; 3(4):239-48. DOI: 10.1007/s12015-007-9001-1. View

Bianco P, Robey P, Simmons P . Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008; 2(4):313-9. PMC: 2613570. DOI: 10.1016/j.stem.2008.03.002. View

10.

Loh S, Chang E, Galvez M, Thangarajah H, El-ftesi S, Vial I . SDF-1 alpha expression during wound healing in the aged is HIF dependent. Plast Reconstr Surg. 2009; 123(2 Suppl):65S-75S. DOI: 10.1097/PRS.0b013e318191bdf4. View

11.

Yoon K, Chae Y, Cho J . FGF2 stimulates SDF-1 expression through the Erm transcription factor in Sertoli cells. J Cell Physiol. 2009; 220(1):245-56. DOI: 10.1002/jcp.21759. View

12.

Itoh T, Nozawa Y, Akao Y . MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem. 2009; 284(29):19272-9. PMC: 2740552. DOI: 10.1074/jbc.M109.014001. View

13.

Granero-Molto F, Weis J, Miga M, Landis B, Myers T, ORear L . Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells. 2009; 27(8):1887-98. PMC: 3426453. DOI: 10.1002/stem.103. View

14.

Shi Q, Hodara V, Butler S, Thomas Iii C, Hubbard G, VandeBerg J . Differential bone marrow stem cell mobilization by G-CSF injection or arterial ligation in baboons. J Cell Mol Med. 2010; 13(8B):1896-1906. PMC: 3032010. DOI: 10.1111/j.1582-4934.2008.00405.x. View

15.

Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G . miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ. 2011; 18(10):1628-39. PMC: 3172120. DOI: 10.1038/cdd.2011.42. View

16.

Davalos V, Moutinho C, Villanueva A, Boque R, Silva P, Carneiro F . Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene. 2011; 31(16):2062-74. PMC: 3330264. DOI: 10.1038/onc.2011.383. View

17.

Tomankova T, Petrek M, Gallo J, Kriegova E . MicroRNAs: Emerging Regulators of Immune-Mediated Diseases. Scand J Immunol. 2011; 75(2):129-41. DOI: 10.1111/j.1365-3083.2011.02650.x. View

18.

Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O . miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med. 2011; 17(12):1627-35. DOI: 10.1038/nm.2512. View

19.

Delk N, Farach-Carson M . Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells. Autophagy. 2012; 8(4):650-63. PMC: 3405839. DOI: 10.4161/auto.19226. View

20.

Zhang Y, Khan D, Delling J, Tobiasch E . Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. ScientificWorldJournal. 2012; 2012:793823. PMC: 3317548. DOI: 10.1100/2012/793823. View